Skipping lymph node biopsy after chemotherapy for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests if it's safe to skip a sentinel lymph node biopsy (a procedure to check if cancer has spread to the lymph nodes under your arm) when the breast tumor has completely disappeared after chemotherapy. If the trial finds it's safe, you could avoid this extra surgery and its side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have HER2-positive or triple-negative breast cancer that has spread into nearby tissue but not to distant organs.
- You have received at least 3 cycles of chemotherapy before surgery.
- Before chemotherapy, an MRI and other imaging (ultrasound or PET/CT) showed no cancer in your lymph nodes.
- An MRI after or during chemotherapy shows the tumor has completely disappeared.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether you can safely avoid a lymph node biopsy in the armpit for early breast cancer when scans and exams look negative. It may reduce surgery-related side effects while still keeping cancer care on track.
This trial tests a less extensive armpit surgery after chemotherapy for breast cancer that had spread to lymph nodes. The goal is to see if removing only the sentinel nodes (guided by blue dye) is safe and effective when nodes appear clear after treatment.
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
This study looks at whether it's safe to do less extensive lymph node surgery (removing only the sentinel node instead of all lymph nodes) for breast cancer that has spread to lymph nodes, after chemotherapy has shrunk the cancer. The goal is to reduce side effects while still effectively treating the cancer.
This study tests whether some women with breast cancer that has spread to lymph nodes can safely avoid a more extensive lymph node surgery after chemotherapy. If the cancer responds well to chemo, a less invasive procedure may be used.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.